Literature DB >> 15836611

Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells.

Ya-Ting Yang1, Tzyh-Chwen Ju, Ding-I Yang.   

Abstract

Compromised mitochondrial function in neurons and glia has been observed in several neurodegenerative disorders, including Huntington's disease and Alzheimer's disease. Chemical/hypoxic preconditioning may afford protection against subsequently more severe oxidative damages. In this study, we tested whether induction of hypoxia inducible factor-1 (HIF-1) may exert cytoprotective effects against mitochondrial dysfunction caused by 3-nitropropionic acid (3-NP) in glial cells. Preconditioning of C6 astroglial cells with cobalt chloride, mimosine (MIM), and desferrioxamine (DFO), all of which known to activate HIF-1, significantly attenuated cytotoxicity induced by 3-NP, an irreversible inhibitor of mitochondrial complex II, and antimycin A, a mitochondrial complex III inhibitor. Application of cadmium chloride capable of neutralizing cobalt-induced HIF-1 activation, HIF-specific oligodeoxynucleotide (ODN) decoy, and antisense phosphorothioate ODN against HIF-1alpha abolished the protective effect mediated by preconditioning with cobalt chloride. Preloading of C6 cells with SN50, PD98059, or SB202190, the respective inhibitor of nuclear factor-kappaB (NF-kappaB), p44/p42 extracellular signal-regulated kinase (ERK), and p38 mitogen-activated protein kinase (MAPK), failed to affect the protection afforded by cobalt preconditioning. Taken together, these results suggest that HIF-1 induction secondary to preconditioning with cobalt chloride or iron chelators may mediate the protective effects against metabolic insult induced by the mitochondrial inhibitor 3-NP in C6 astroglial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15836611     DOI: 10.1111/j.1471-4159.2005.03032.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

1.  The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Authors:  Randall L Davis; Subhas Das; J Thomas Curtis; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2015-05-22       Impact factor: 4.432

Review 2.  Hypoxia inducible factor-1 as a target for neurodegenerative diseases.

Authors:  Z Zhang; J Yan; Y Chang; S ShiDu Yan; H Shi
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Ethyl 3,4-dihydroxy benzoate, a unique preconditioning agent for alleviating hypoxia-mediated oxidative damage in L6 myoblasts cells.

Authors:  Charu Nimker; Gurpreet Kaur; Anshula Revo; Pooja Chaudhary; Anju Bansal
Journal:  J Physiol Sci       Date:  2014-11-08       Impact factor: 2.781

4.  Acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in the mouse kidney.

Authors:  Mitsuko Iguchi; Yoshihiko Kakinuma; Atsushi Kurabayashi; Takayuki Sato; Taro Shuin; Seung-Beom Hong; Laura S Schmidt; Mutsuo Furihata
Journal:  Nephron Exp Nephrol       Date:  2008-10-27

5.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

Review 6.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

Review 7.  Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke.

Authors:  Rachel E Speer; Saravanan S Karuppagounder; Manuela Basso; Sama F Sleiman; Amit Kumar; David Brand; Natalya Smirnova; Irina Gazaryan; Soah J Khim; Rajiv R Ratan
Journal:  Free Radic Biol Med       Date:  2013-01-31       Impact factor: 7.376

8.  Β-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytes.

Authors:  Randall L Davis; Subhas Das; Daniel J Buck; Craig W Stevens
Journal:  Neurochem Int       Date:  2013-01-31       Impact factor: 3.921

9.  Activation of the prereplication complex is blocked by mimosine through reactive oxygen species-activated ataxia telangiectasia mutated (ATM) protein without DNA damage.

Authors:  Shoichi Kubota; Yasunori Fukumoto; Kenichi Ishibashi; Shuhei Soeda; Sho Kubota; Ryuzaburo Yuki; Yuji Nakayama; Kazumasa Aoyama; Noritaka Yamaguchi; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-01-13       Impact factor: 5.157

10.  HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease.

Authors:  Zoya Niatsetskaya; Manuela Basso; Rachel E Speer; Stephen J McConoughey; Giovanni Coppola; Thong C Ma; Rajiv R Ratan
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.